Clinical Trial Update: Efficacy and Safety of PARPi to Treat Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing PARP inhibitor efficacy and safety in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Sheba Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED